News
$Sellas Life Sciences (SLS.US)$ Reuters· 1 min ago
Sellas Announces U.S. FDA Rare Pediatric Disease Designation (Rpdd) Granted to Galinpepimut-S (Gps) for the Treatment of Pediatric Acute Myeloid Leukemia
Sellas Announces U.S. FDA Rare Pediatric Disease Designation (Rpdd) Granted to Galinpepimut-S (Gps) for the Treatment of Pediatric Acute Myeloid Leukemia
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
steven smith38 : yessssssssssssssssssssssssss about to blowww up.
steven smith38 : try in at 1.23. yesss
Trytosaveabit OP steven smith38 : GL